Anthropic makes its IPO filing public, with a Nasdaq ticker of ANT

Anthropic said on X on October 26 that it has filed an S-1 registration statement with the SEC for its proposed initial public offering. According to the company, it plans to list Class A common stock on Nasdaq under the symbol ANT.

The post links to a short notice on Anthropic’s own site, and that notice is thin on numbers. It says Anthropic, PBC filed the Form S-1 on October 26, 2026. It gives no share count, no price range, no financial figures and no date for pricing or first trade.

A ticker and two banks, but no price yet

The notice says the shares are planned for the Nasdaq Global Select Market. It names Goldman Sachs and Morgan Stanley as the places to request copies of the preliminary prospectus, which indicates both banks are involved in the offering. The notice does not call them lead underwriters, and it does not say whether other banks are involved.

Anthropic also repeats the standard legal language. The registration statement has been filed but has not become effective. The securities cannot be sold, and offers to buy cannot be accepted, until it does. The post is not an offer to sell or a solicitation to buy.

For ordinary readers this means no one can buy ANT shares yet. Pricing normally follows a roadshow and SEC clearance, and the notice sets no schedule for either.

From a confidential draft to a public document

The step is the second public marker in a process that began months earlier. On June 1, Anthropic said in another post on X that it had confidentially submitted a draft S-1 to the SEC. It described that as giving the company the option to pursue an IPO once the SEC review was complete.

A confidential draft does not commit a company to anything. A public S-1 is different in kind, because it puts the business, its risk factors and its financial statements in front of any investor who wants to read them. That is the document that investors, analysts and competitors will now go through. Anthropic’s notice does not say what the filing contains, so the contents are not yet part of this story.

The notice also does not settle whether the company has chosen its dual-class structure terms, how many shares it will sell, or whether existing holders will sell. Those details would sit in the prospectus itself, which the announcement does not reproduce.

What the filing will have to show, and what it cannot yet

The angle here is the numbers in context, and the context is that the key numbers are still missing. Two facts frame what readers can compare once they arrive.

First, the timeline has moved at a steady pace: the confidential submission on June 1 and the public S-1 on October 26 are almost five months apart. Second, the filing arrives while Anthropic is also facing litigation. As we reported earlier today, Elvis Presley’s rightsholders sued Anthropic over 274 songs, seeking $41 million. That figure is a claim by the plaintiffs, not a finding, and Anthropic’s response is covered in that article. A public prospectus normally has to describe legal proceedings that are material to the business, so how it treats copyright suits is something to watch for once the text is read.

Outside reports on valuation and fundraising targets circulate, but Anthropic’s notice confirms none of them, and this article does not rely on them. Until the prospectus numbers can be read directly, any valuation figure is an estimate by someone other than the company.

What readers can and cannot do now

Nothing is open to retail or institutional buyers today. The next visible steps would be an amended filing with a price range and share count, then a roadshow, then pricing. Anthropic’s announcement commits to none of these dates.

What the announcement establishes is narrow: a public S-1 exists, the planned venue is Nasdaq, the planned symbol is ANT, and Goldman Sachs and Morgan Stanley are listed as contacts for the preliminary prospectus. Everything else, including revenue, losses, governance and use of proceeds, has to come from the filing itself, which this article has not been able to review.